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Abstract
Torque teno viruses (TTVs) are a group of viruses with small, circular DNA genomes. Members of this family are thought to
ubiquitously infect humans, although causal disease associations are currently lacking. At present, there is no understanding
of how infection with this diverse group of viruses is so prevalent. Using a combined computational and synthetic approach,
we predict and identify miRNA-coding regions in diverse human TTVs and provide evidence for TTV miRNA production in
vivo. The TTV miRNAs are transcribed by RNA polymerase II, processed by Drosha and Dicer, and are active in RISC. A TTV
mutant defective for miRNA production replicates as well as wild type virus genome; demonstrating that the TTV miRNA is
dispensable for genome replication in a cell culture model. We demonstrate that a recombinant TTV genome is capable of
expressing an exogenous miRNA, indicating the potential utility of TTV as a small RNA vector. Gene expression profiling of
host cells identifies N-myc (and STAT) interactor (NMI) as a target of a TTV miRNA. NMI transcripts are directly regulated
through a binding site in the 39UTR. SiRNA knockdown of NMI contributes to a decreased response to interferon signaling.
Consistent with this, we show that a TTV miRNA mediates a decreased response to IFN and increased cellular proliferation in
the presence of IFN. Thus, we add Annelloviridae to the growing list of virus families that encode miRNAs, and suggest that
miRNA-mediated immune evasion can contribute to the pervasiveness associated with some of these viruses.
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Introduction
Torque teno viruses (TTVs) belong to the family Anelloviridae
and have small (,3.8 kb) circular, ssDNA genomes [1]. While
these viruses are compact in their genomic size, there is a
surprising amount of diversity reported in viral isolates, and the
human TTVs have been phylogenetically classified into five
groups [2–4]. The first TTV like sequence was isolated from a
patient with non-A–G hepatitis [5]; however, TTVs are not
currently thought to have a causal role in such disease and no
concrete disease associations currently exist [6]. Despite the
current lack of clear disease associations, TTVs are considered
near ubiquitous in the human population and appear to establish
persistent infections in their host [6]. Exactly how TTVs are able
to evade clearance by the host immune response and establish long
term persistent infections remains a mystery which solving may
require the identification of the full complement of TTV gene
products and their functions.
MicroRNAs (miRNAs) are small ,22 nt noncoding RNAs that
direct posttranscriptional gene regulation. miRNAs were first
identified in the nematode C. elegans [7], but since have been
recognized as important regulators of gene expression in many
eukaryotes and even viruses [8]. Diverse viruses including some
members from the Herpesvirus, Polyomavirus, and Retrovirus
families have been confirmed to encode viral miRNAs [9]. While
these virus families are different in many ways, they do share some
commonalities including a nuclear DNA component to their
replicative cycle and the ability to establish persistent infections in
their hosts. Emerging themes of viral miRNA function include
immune evasion, prolonging longevity of host cells, and regulation
of persistent versus productive infection [9–11]. Unlike most
protein-based viral gene products, viral miRNAs are thought to be
relatively invisible to the host immune system [8] and require
minimal genomic space for their encoding.
The extent to which different virus families utilize miRNAs
remains a fundamental question in the field of viral miRNAs. To
address this question we have previously developed computational
methods to predict miRNA genes from primary sequence
information [12]. Using this approach as a starting point, we
investigated the TTV family for the potential to encode miRNAs.
A diverse group of viral miRNAs encoded by TTVs were
identified and their interactions with the host miRNA biogenesis
pathway characterized. We have generated recombinant TTVs
capable of expressing a small RNA transgene as well as a miRNA
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mutant virus to study miRNA function. Gene expression profiling
led to the discovery of a direct target of a TTV miRNA, N-myc
(and STAT) interactor (NMI). NMI is an interferon stimulated
gene known to modulate interferon and cytokine signaling [13]
and has been previously associated with viral induced apoptosis
[14]. Furthermore, we demonstrate an inhibitory role for a TTV
miRNA in interferon signaling. Our findings support the model
that TTVs make use of viral miRNAs to modulate the innate
immune response and promote their persistence.
Results
A Combined Computational and Synthetic Approach
Identifies TTV Encoded miRNAs
We investigated TTV genomic sequences for miRNA gene
candidates using previously described computational methods that
predict candidate pre-miRNAs [12]. Since most miRNAs are not
coded within protein coding sequences, our search for predicted
miRNA candidates focused on regions of the viral genomes lacking
protein coding sequence annotation. This restriction has the added
advantage of significantly reducing the search space. Candidate
pre-miRNA sequences in multiple human TTVs were observed
within an unannotated region between the poly A signal of the
known viral transcripts and the canonical promoter region
(Figure 1A, Table S1). Some TTV strains had a single pre-
miRNA-like stemloop prediction, while other strains had two pre-
miRNA-like stemloop predictions in this region (Figure 1A). We
therefore chose to test predictions from both classes. The
candidate viral pre-miRNA sequences were commercially synthe-
sized and tested by transfection of HEK293T cells followed by
Northern blot analysis. This revealed readily detectable signals
migrating at the appropriate sizes that corresponded to the
predicted derivative miRNA sequences (Figures 1B, 1D). Based on
these results, promising candidates were also subjected to high
throughput small RNA sequencing to look for features common to
bona fide miRNAs. The small RNA sequencing libraries
contained small RNA reads that mapped specifically to the
predicted pre-miRNA sequences (Figures 1C, 1E). Importantly,
these small RNAs displayed the features expected of true
miRNAs– predominant derivatives arising from each arm of the
stem loop structure and predicted 39 ,2 nucleotide overhangs
(Figure 1A). Taken together, these results strongly support the
production of miRNAs from the computationally predicted,
synthetic constructs.
Next, we asked whether TTV derived miRNAs are detectable
during viral replication. We chose to utilize a previously described
cell culture based replication system using the TTV-tth8 strain
[4,15]. The TTV-tth8 strain has one predicted miRNA stemloop
located in the non-coding region (NCR) (Figure 2A). Northern blot
analysis was performed on total RNA extracted from the
replication system as well as from HEK293T cells transfected
with a synthetic vector containing the predicted miRNA sequence
(Figure 2B). Similar signals consistent with detection of both the
pre-miRNA and a mature miRNA were observed from both our
synthetic construct and the viral replication system. These data
confirm that TTV-encoded miRNAs are produced during
replication of the TTV-tth8 genome in cell culture.
To determine whether TTV viral miRNAs are expressed in vivo,
small RNA libraries deposited in the NCBI Sequence Read
Archive (SRA) were examined [16]. A data set deposited by Vaz et
al included two small RNA sequencing libraries derived from
primary human PBMCs from apparently healthy individuals [17].
These small RNA libraries were mapped to a collection of
deposited TTV and TTV-like viral genomes (Table S2). Of the
two samples we examined, one of the libraries (SRR039191)
contained reads mapping specifically to predicted miRNA
stemloop structures of TTV-sle2057 and related strains
(Figure 2C). While the total number of reads mapped to TTV
miRNAs was low, this might be expected since only a small
fraction of the PBMC population would be expected to harbor the
virus and the total number of reads sequenced was relatively small
(,3 million total reads). Furthermore, the fact that the reads
mapped only to the exact miRNA predicted structures and not
elsewhere in the viral genome or the human genome, strongly
supports the sequences being of viral origin. Thus, we conclude
that TTV-encoded miRNAs are expressed in their human hosts
during infection.
Diversity of Anellovirus Encoded miRNAs
The Anellovirus family includes the torque teno viruses (TTVs),
torque teno midi viruses (TTMDVs), torque teno mini viruses
(TTMVs), as well as related nonhuman animal viruses [2]. The
TTMDVs and TTMVs share similar genomic organization with
TTV but have significantly shorter genomic sequences. A
computational based search for predicted miRNA-like sequences
was carried out on deposited TTV and the related TTMDV and
TTMV genomic sequences (Table S1). No strong miRNA
candidates were identified from either the TTMDVs or TTMVs
(data not shown). It is worth noting that many of the deposited
TTMDV and TTMV sequences have a much shorter NCR than
TTVs. This observation may in large part be due to the
incomplete nature of some submitted viral genomic sequences.
While our initial bioinformatics strategy failed to identify likely
candidates in these sequences we cannot rule out the possibility
they were missed by our bioinformatics analysis or due to a lack of
verified full length genomic sequences.
TTV tth8 miRNA Is Processed by the Canonical Host
miRNA Pathway
The majority of known human and viral miRNAs follow a
canonical biogenesis pathway that begins with transcription by
host RNA polymerase II. The pri-miRNA transcript is cleaved by
the enzyme Drosha, which is the nuclease component of the
Microprocessor complex, to liberate the short stem loop pre-
miRNA [18]. The pre-miRNA may then be exported to the
cytoplasm whereupon it is cleaved by a second nuclease, Dicer, to
generate a short ,22 nt duplex RNA [19]. Typically, one strand
of this duplex RNA is loaded into the RNA Induced Silencing
Author Summary
The torque teno viruses (TTVs) are a diverse group of
viruses that ubiquitously infect humans and establish
persistent infections. Despite their prevalence, TTVs lack
concrete disease associations and remain among the most
poorly characterized human viruses. Here we use compu-
tational and synthetic approaches to identify new non-
coding miRNA genes in the TTVs. We demonstrate that
TTVs utilize the host miRNA biogenesis machinery to
produce biologically active miRNAs. To gain a functional
understanding of the new TTV genes, we focus on a
particular viral isolate and identify N-myc (and STAT)
interactor (NMI) as a direct target. NMI is a known
modulator of interferon and cytokine signaling. Similar to
other viruses encoding miRNAs, the TTVs likely utilize
miRNAs to promote persistence and immune evasion. Our
study provides new insights into novel TTV gene products
and the interactions of this virus with its host.
Viral MicroRNA Inhibits Interferon Signaling
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Complex (RISC) where it may direct RISC mediated repression to
target RNAs [20]. While most host miRNAs and viral miRNAs
utilize this common pathway, notable exceptions have been
reported from both the herpesvirus and retrovirus families
[12,21,22].
Our miRNA biogenesis and functional characterization focused
on TTV isolate tth8 (TTV-tth8) due to the availability of an in vitro
cell culture virus genome replication system [4,15]. We began by
investigating the mode of transcription. Treatment of cells with an
appropriate concentration of a-amanitin inhibits RNA polymerase
II transcription but not transcription by RNA polymerase III [21].
HEK293 cells were transfected with re-circularized TTV tth8 viral
genome in the presence or absence of a-amanitin and then
miRNA expression was assayed by Northern blot. As controls, a
recombinant TTV expressing the SV40-miR-S1 miRNA– an
RNA pol II dependent miRNA, or vector encoding the RNA pol
III-transcribed miRNA MHV68-miR-M1-7 were also tested. As
shown in Figure 3A, the expression of the positive control SV40-
miR-S1 and TTV-tth8-miR-T1 miRNAs are both inhibited by a-
amanitin, while as expected, the negative control pol III-
dependent MHV68-miR-M1-7 miRNA was resistant to treat-
ment. In addition, we observed similar results when transfecting
HEK293T cells with vectors containing our synthetic TTV
miRNA candidates (Figure S1A). These data are consistent with
the TTV miRNAs being derived from RNA pol II transcripts,
similar to most previously described host and viral miRNAs.
Figure 1. A combined computational and synthetic approach identifies TTV encoded miRNAs. (A) Diagram of genomic locations of
predicted TTV-yonKC197 (AB038624) and TTV-TWH (AFL351132) miRNAs. Reference sequence annotated ORFs are indicated in red and predicted
miRNA stemloop sequences are indicated in blue. Secondary structure predictions of the putative TTV miRNAs are shown to the right with bolded
sequences indicating most abundant mature miRNA sequences observed in small RNA sequencing library. (B) Northern blot analysis of RNA
harvested from HEK293T cells transfected with synthetic TTV-yonKC197 miRNA vector (SG for ‘‘synthetic gene’’) or empty vector (NC). Ethidium
bromide stained low molecular weight RNA is shown as a load control. (C) Northern blot analysis of RNA harvested from HEK293T cells transfected
with synthetic TTV-TWH miRNA vector (SG) or empty vector (NC). Ethidium bromide stained low molecular weight RNA is shown as a load control. (D)
Pooled small RNA profiling of HEK293T cells transfected with TTV-yonKC197 miRNA vector. Sequences were mapped to the synthetic region of the
AB038624 NCBI reference sequence. The vertical axis depicts small RNA read coverage observed; while the horizontal axis shows the relative position
within the synthetic gene sequence. (E) Pooled small RNA profiling of HEK293T cells transfected with TTV-TWH miRNA vector. Sequences were
mapped to the synthetic region of the AFL351132 NCBI reference sequence. The vertical axis depicts small RNA read coverage observed; while the
horizontal axis shows the relative position within the synthetic gene sequence.
doi:10.1371/journal.ppat.1003818.g001
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Next, we investigated the role of Drosha, the endonuclease
component of the Microprocessor responsible for excising pre-
miRNAs from pri-miRNA transcripts. HEK293Tcells were
transfected with siRNA directed against Drosha [23] (or negative
control siRNAs) followed by transfection of miRNA expression
vectors and Northern blot analysis. Drosha-dependent SV40-miR-
S1 miRNA, or the Drosha-independent MHV68-miR-M1-7
miRNA expression vectors, were used as controls. As expected,
the Drosha siRNA treatment inhibited expression of the SV40-
miR-S1 miRNA, but did not have a significant effect on the
expression of the MHV68-miR-M1-7 miRNA (Figure 3B). The
effect of the Drosha siRNA treatment with the TTV-tth8-miR-T1
expression vector was similar to the SV40-miR-S1 miRNA.
Furthermore, similar results were observed when transfecting
HEK293T cells with vectors containing our synthetic TTV
miRNA candidates (Figure S1B). Therefore, we conclude that
the TTV miRNAs are processed in a Drosha-dependent manner
similar to most previously described host and viral miRNAs.
Dicer is the endonuclease responsible for processing pre-miRNAs
into mature miRNA duplex RNAs. DLD1-DicerEx5- is a Dicer-
activity-hypomorphic cell line which exhibits impaired conversion
of pre-miRNAs to mature miRNAs [24]. This defect results in
decreased Dicer-processed mature miRNA production and an
accumulation of pre-miRNA substrate. TTV-tth8-miR-T1, or the
positive control Dicer-dependent MHV68-miR-M1-7 miRNA
expression vectors, were transfected into the Dicer hypomorph or
isogenic wild type Dicer parental cell lines and then assayed by
Northern blot (Figure 3C). Like the MHV68-miR-M1-7 control, a
pre-miRNA:miRNA ratio change consistent with Dicer processing
was observed with TTV-tth8-miR-T1. Thus, we conclude that the
TTV-tth8 miRNAs are processed in a Dicer-dependent manner
similar to most previously described host and viral miRNAs.
The final step in the canonical miRNA biogenesis pathway is
the incorporation of the mature miRNA into active RISC.
Luciferase based reporter constructs specific to each arm of TTV-
tth8-miR-T1 miRNA were generated to test for RISC activity.
The luciferase based reporter constructs were co-transfected with a
TTV-tth8-miR-T1 miRNA expression vector, or control vector,
and then dual luciferase assays were performed (Figure 3D). The
relative expression of either TTV-tth8 reporter construct was
significantly inhibited by co-transfection of the TTV-tth8-miR-T1
expression vector, while no significant difference was observed
Figure 2. TTV miRNAs are expressed during in vitro cell culture replication and are detectable from in vivo small RNA profiling of
human PBMCs. (A) Diagram of genomic locations of predicted TTV-tth8 (AJ260231) miRNA. Reference sequence annotated ORFS are indicated in
red and predicted miRNA stemloop sequence is indicated in blue. Secondary structure prediction of the putative TTV miRNA is shown below with
bolded sequences indicating most abundant mature miRNA sequences observed in small RNA sequencing library. (B) Northern blot analysis of RNA
harvested from HEK293T cells transfected with synthetic TTV-tth8 miRNA vector (SG) or empty vector (NC) and HEK293TT cells transfected with viral
genome prep (TTV) or mock transfection (Mock). Northern blot analysis for host miRNA hsa-miR-19a and ethidium bromide stained low molecular
weight RNA serve as load controls. (C) Small RNA profiling of human PBMC small RNAs mapped to TTV-sle2057 strain. The vertical axis depicts small
RNA read coverage observed; while the horizontal axis shows the relative position within the TTV-sle2057 genomic sequence.
doi:10.1371/journal.ppat.1003818.g002
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with either of two negative controls– vector 39UTR or an
irrelevant GAPDH 39UTR reporter. Similar results were observed
with our synthetic TTV miRNA candidates and corresponding
reporter constructs (Figure S1C). Therefore, we conclude that the
TTV miRNAs are active in RISC.
Taken together, we have identified the general pathway through
which biologically active miRNAs are generated. The evidence
presented is most consistent with direct utilization of the canonical
host miRNA biogenesis machinery.
Generation and Characterization of Recombinant TTVs
A mutant TTV-tth8 with ablated miRNA production (TTV-
MUT) was generated by introduction of a specific 4 nt deletion
into the miRNA stem region (Figure 4A). A recombinant TTV
was generated by inserting the SV40-miR-S1 sequence into the
same genomic position. Generation of this TTV-SV40 recombi-
nant virus (TTV-SV40) serves two purposes: (1) As an additional
control in our functional analysis and, (2) As an initial test of the
TTV as a potential small RNA vector. HEK293TT cells were
transfected with circularized viral genome preparations and
assayed for miRNA expression by Northern blot analysis
(Figure 4B). As expected, we were unable to detect production
of the TTV-tth8-miR-T1 from TTV-MUT or TTV-SV40.
However, we were able to detect the production of the SV40-
miR-S1 from TTV-SV40 recombinant as anticipated. Thus, we
have successfully generated a surgical miRNA mutant virus and
Figure 3. TTV tth8 miRNAs are generated by the canonical host miRNA biogenesis pathway. (A) Northern blot analysis of RNA from
HEK293 cells transfected with MHV68-miR-M1-7 expression vector, SV40-miR-S1 TTV recombinant genome preparation, or wildtype TTV-tth8 genome
preparation with or without treatment with the RNA pol II inhibitor a-amanitin. Ethidium bromide stained low molecular weight RNA is shown as a
load control. (B) Northern blot analysis of RNA from HEK293T cells co-transfected with MHV68-miR-M1-7, SV40-miR-S1, or TTV-tth8-miR-T1 expression
vectors and either Drosha siRNA (siDrosha) or negative control siRNA (siNC). Ethidium bromide stained low molecular weight RNA is shown as a load
control. (C) Northern blot analysis of RNA from either DLD1 (WT) or DLD1DicerEx5- (DicerEx5-) cells transfected with either MHV68-miR-M1-7 or TTV-
tth8-miR-T1 expression vectors. Ethidium bromide stained low molecular weight RNA is shown as a load control. (D) RISC reporter assay for TTV-tth8-
miR-T1. HEK293 cells were co-transfected with either empty miRNA expression vector (Vector) or TTV-tth8-miR-T1 expression vector (TTH8) and both
control firefly luciferase reporter and Renilla luciferase based reporter plasmids with vector UTR (Vector), two sites perfectly complementary to TTV-
tth8-miR-T1-5p (5p), two sites perfectly complementary to TTV-tth8-miR-T1-3p (3p), or control 39UTR reporter with GAPDH 39UTR (GAPDH). The
average relative Renilla luciferase activity normalized to firefly luciferase activity of three replicates is shown. Error bars indicate SD of three replicates
and p-values were calculated using Student’s t-test.
doi:10.1371/journal.ppat.1003818.g003
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have demonstrated the capacity of the TTV-tth8 virus to express
an exogenous miRNA.
While we have shown that TTV-MUT does not produce TTV-
tth8-miR-T1, it was still possible that other miRNAs could be
encoded by the virus that our prediction methods missed. To
address this concern and better characterize the miRNAs encoded
by TTV-tth8, high throughput small RNA sequencing was
performed on small RNA fractions harvested from the cell culture
replication system for both the wildtype TTV-tth8 and TTV-
MUT (Figure 5). As expected, abundant small RNA reads
mapping to TTV-tth8-miR-T1 were observed for the wildtype
virus but not TTV-MUT. Interestingly, a lesser amount of
antisense mapping reads were observed for TTV-tth8-miR-T1,
which would be indicative of transcription and specific processing
of the antisense strand as well. We note that it has previously been
reported that TTV replication generates antisense transcripts of
unknown function [15]. However, no pattern of reads indicative of
miRNA production was observed from TTV-MUT or additional
outside of the TTV-tth8-miR-T1 locus in the wildtype virus.
Therefore, we conclude that TTV-tth8 encodes miRNAs at a
single locus and we have successfully generated a miRNA null
variant.
We hypothesized that the disruption of TTV-tth8-miR-T1
would alter viral replication dynamics. To test this hypothesis,
timecourse experiments were performed with TTV-tth8 and
TTV-MUT in the cell culture replication system. DpnI protection
assays were performed to differentiate between replicated and
non-replicated viral DNA [4,25]. DpnI is a restriction endonucle-
ase that recognizes only a methylated form of the restriction site.
The viral genomic DNA prepared from bacterial stocks is
methylated while viral DNA that is replicated in the HEK293TT
cells will not be methylated at the restriction site. DpnI protection
assays followed by Southern blot analysis were performed on DNA
harvested at timepoints up to 9 days post initial transfection
(Figure S2). We did not observe any gross differences in viral
genome replication between the wildtype (WT) and mutant
(MUT) viruses in this assay. However, we note that similar lack
of cell culture replication defects have been reported for some
miRNA mutant viruses from the polyoma and herpes families in
cell culture [26,27], and that this result does not rule out the
possibility for replication differences in vivo.
Identification of TTV-tth8-miR-T1 Targets by Microarray
Analysis
Programming of RISC with a mature miRNA sequence directs
the complex to target mRNAs resulting in translational repression
and enhanced turnover of some of the target mRNAs [28,29]. The
enhanced turnover of target mRNAs can result in lower steady
state transcript levels that can be detected via microarray analysis
[30–34]. As a preliminary investigation of possible host targets for
TTV-tth8-miR-T1, microarray analysis for human transcripts was
performed on RNA harvested from HEK293TT cells transfected
with TTV-tth8, TTV-MUT, TTV-SV40, or pUC control vector.
To identify candidate direct targets, the following criteria were
applied: putative targets must be lower in the wildtype sample than
the mutant or SV40 control and a seed complementary sequence
must be present in the 39UTR sequence of the candidate. Using
this approach, 16 candidates were identified that were differen-
tially expressed between the samples and that possessed seed
complementary sequences in their 39UTRs (Table S3). We caution
that such analysis should be used for preliminary hypothesis
generation, and subsequent confirmation experiments are required
to establish direct effects. Examining the list for candidates with
known functions in viral infection led us to the gene N-myc (and
Figure 4. Generation of mutant and SV40 recombinant TTVs. (A) RNA secondary structure predictions of miRNA region from TTV-tth8
wildtype, TTV-tth8 miRNA mutant, and TTV-tth8 SV40 recombinant viruses. (B) Northern blot analysis of total RNA harvested from HEK293TT cells
transfected with either pUC plasmid (Vector), wildtype TTV-tth8 (TTH8 WT), miRNA mutant TTV-tth8 (TTH8 MUT), or SV40 miRNA recombinant TTV-
tth8 (TTH8 SV40). Northern blot analysis for host miRNA hsa-miR-19a and ethidium bromide stained low molecular weight RNA serve as load controls.
doi:10.1371/journal.ppat.1003818.g004
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STAT) interactor (NMI). As an interferon stimulated gene (ISG)
[35], a regulator of STAT signaling [13], and because of its
involvement in virus-induced apoptosis [14], we chose to further
investigate this putative target.
NMI Is a Direct Target of TTV-tth8-miR-T1
We identified a putative miRNA binding site for the more
abundant 5p arm of TTV-tth8-miR-T1 in the 39UTR of NMI
(Figure 6A). To test whether TTV-tth8-miR-T1 can directly target
this sequence, luciferase reporter constructs with the full length
NMI 39UTR as well as a reporter construct with the full length
NMI 39UTR with a 2 nt change in the predicted seed docking site
were generated. HEK293T cells were co-transfected with the
luciferase based reporter constructs and a TTV-tth8-miR-T1
miRNA expression vector, SV40-miR-S1 vector, or control vector
and dual luciferase assays were performed (Figure 6B). The
relative expression of the NMI 39UTR reporter construct was
significantly inhibited by co-transfection of the TTV-tth8-miR-T1
expression vector while no significant difference was observed with
vector 39UTR control or an irrelevant GAPDH 39UTR reporter
control. Importantly, no significant difference was observed when
the seed mutant 39UTR reporter was co-transfected with the tth8-
miR-T1 expression vector, which strongly supports that the
regulation observed is through docking at our predicted miRNA
target site.
While TTV-tth8-miR-T1 can directly regulate reporter con-
structs bearing the NMI 39UTR, we next wanted to know if TTV-
tth8-miR-T1 can regulate expression of NMI protein from
endogenous NMI transcripts. A miRNA mimic of TTV-tth8-
miR-T1 was synthesized based on the sequences from our small
RNA profiling experiments. HeLa cells were transfected with the
viral miRNA mimic or negative control miRNA mimic and NMI
protein levels were assayed by immunoblot analysis (Figure 6C). A
modest but highly reproducible decrease in NMI protein levels
(,25%) with TTV-tth8-miR-T1 mimic transfection was observed
in three independent experiments (Figure 6D). Therefore, we
conclude that NMI is a direct target of TTV-tth8-miR-T1.
TTV-tth8-miR-T1 miRNA Mimic or siRNA Targeting NMI
Inhibits Interferon Signaling
NMI has previously been shown to modulate STAT signaling
pathways in response to cytokine stimulation. A luciferase based
interferon signaling assay was employed to determine whether
TTV-tth8-miR-T1 can modulate interferon signaling activity
(Figure 7A). Dual luciferase assays were performed on HEK293T
cells co-transfected with circularized viral genomes or control
plasmid and luciferase reporters and subsequently treated with
universal type I interferon (Figure 7B). Relative to control plasmid,
a ,40% decrease in ISRE driven luciferase activity was observed
with wildtype TTV-tth8 while a ,18% decrease was observed
with the miRNA mutant TTV-tth8. Although additional viral
factors may contribute to the decreased activity in this assay, a
significantly larger decrease was observed with the miRNA
competent virus.
To further investigate the effects of TTV-tth8-miR-T1 and
NMI on interferon signaling, interferon reporter assays were
performed with synthetic miRNA mimics or siRNA directed
against NMI (Figures 7C, S3). Relative to control mimic,
transfection of HEK293T cells with the TTV-tth8-miR-T1 mimic
resulted in a significant reduction in expression of the ISRE driven
reporter (,50%) (Figure 7C). Transfection of siRNA targeted
against NMI resulted in a similar reduction in reporter expression.
However, co-transfection of both siRNA against NMI and TTV-
tth8-miR-T1 mimic did not exhibit an additive effect. Similar
results were observed in experiments conducted in HeLa cells
(Figure S3B). To determine if the interferon reporter assays were
reflective of endogenous ISRE activity, quantitative Real-Time
PCR (qRT-PCR) for an endogenous ISG transcript (ISG15) was
Figure 5. Characterization of wildtype and miRNA mutant TTV-tth8. Small RNA profiling of HEK293TT cells transfected with either wildtype
TTV-tth8 (WT) or miRNA mutant TTV-tth8 (MUT). At top, ORF map derived from NCBI reference sequence AJ260231 annotations in red. The newly
identified miRNA is indicated in blue. The vertical axis depicts small RNA read coverage observed; while the horizontal axis shows the relative position
within the TTV-tth8 genomic sequence.
doi:10.1371/journal.ppat.1003818.g005
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performed on RNA extracted from HEK293T cells treated with
interferon (Figure 7D). Relative ISG15 levels were significantly
reduced (,40%) with transfection of either TTV-tth8 miRNA
mimic or NMI siRNA with respect to negative control miRNA
mimic or siRNA. These results provide support that the luciferase-
based ISRE reporter system is reflective of endogenous ISRE
activity. Although we cannot rule out that additional targets of
TTV-tth8-miR-T1 contributed to the decreased reporter activity,
the evidence presented suggests that targeting of NMI by TTV-
tth8-miR-T1 contributes to decreased interferon signaling.
Finally, we examined the effects of TTV-tth8 miRNA expression
on cells exposed to interferon. We chose a low passage PBMC-
derived human B-cell line since PBMCs likely serve as host cells to
TTVs in vivo (reviewed in [6]). Pooled stable cell lines expressing
either the TTV-tth8 miRNA, an irrelevant control miRNA, or
vector were generated by lentiviral transduction of human B-cell
line GM19240. Growth curves were calculated for all three cell lines
in the presence or absence of interferon (Figure 7E). All three cell
lines grew similarly in the absence of interferon. Treatment with
daily interferon resulted in a marked defect in growth in both
controls cell lines (vector alone and irrelevant miRNA). In contrast,
in the presence of IFN treatment, the TTV-tth8 miRNA-expressing
cell line exhibited ,10 fold more viable cells (compared to the
control cell lines) at the conclusion of the growth curve. Therefore,
we conclude that the TTV-tth8 miRNA can promote cell growth/
viability under some interferon-rich conditions.
Discussion
Although the first viral miRNAs were reported over nine years
ago [36], a comprehensive understanding of which virus families
encode miRNAs remains incomplete. In this study we have added
another family, Anelloviridae, to the growing list of virus families
with members encoding miRNAs. This is the first ssDNA virus
reported to encode miRNAs. The TTVs remain among the most
poorly studied of human viruses, perhaps due to a lack of
conclusive disease associations. However, the ability of TTVs to
establish ubiquitous persistent infections implies that studying the
TTVs can reveal important lessons in viral persistence that may be
useful in understanding other virus families as well.
The mechanisms by which TTVs are able to establish persistent
infections and avoid clearance by the immune system remain
elusive. In this study we have demonstrated that some TTVs
encode miRNAs which are thought to be non-immunogenic
regulatory molecules. We hypothesized that TTVs may utilize
these effectors to target transcripts of their host cell. We identified
a direct target of TTV-tth8-miR-T1, NMI. NMI is a transcription
cofactor that can modulate the activity of members of the STAT
family in response to interferon and cytokine signaling [13].
Recently, NMI has been implicated in additional roles including:
inhibition of Wnt/b-catenin signaling [37], tumor suppressive
activity when exogenously expressed in a mouse tumor model
[37], and protection of the tumor suppressor ARF from
Figure 6. Host antiviral gene NMI is a direct target of TTV-tth8-miR-T1. (A) Diagram of predicted TTV-tth8-miR-T1-5p docking site in the
39UTR of NMI transcripts (top) with complementary base pairing to the TTV-tth8-miR-T1-5p (middle) seed indicated (‘‘|’’ for predicted base pairing and
‘‘?’’ for wobble pairing). At bottom is diagrammed the seed mutant (NMI MUT) sequence with the introduced two nucleotide mismatch in the seed
complementary region (underlined sequence). (B) NMI 39UTR miRNA docking site reporter assay. HEK293 cells were co-transfected with either empty
miRNA expression vector (Vector), TTV-tth8-miR-T1 expression vector (TTH8), or SV40-miR-S1 expression vector (SV40) and both control firefly
luciferase control and Renilla luciferase based reporter plasmids with vector UTR (Vector), full length NMI 39UTR (NMI), full length NMI 39UTR with 2 nt
mutation in predicted docking site (NMI MUT), or control 39UTR reporter with GAPDH 39UTR (GAPDH). The average relative Renilla luciferase activity
normalized to firefly luciferase activity of three replicates is shown. Error bars indicate SD of three replicates and p-values were calculated using
Student’s t-test. (C) Immunoblot analysis of total protein harvested from HeLa cells transfected with either TTV-tth8-miR-T1 miRNA mimic (miTTH8) or
negative control miRNA mimic (miNC). Shown is a representative blot. (D) Quantification of the average of three independent experiments as in panel
C. Error bars indicate SD of three independent experiments and p-values were calculated using Student’s t-test.
doi:10.1371/journal.ppat.1003818.g006
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degradation during stress [38]. While our current results support
the idea that TTV-tth8 miRNA targets NMI to inhibit interferon
signaling and promote immune evasion, NMI may not be the only,
or even the major target responsible for the effects of the TTV-
tth8 miRNA that we observe. Furthermore, it is likely that other
functions for the TTV-tth8 miRNA are possible. However, the
observation that expression of the TTV-tth8 miRNA in B-cell lines
provides partial resistance to interferon-induced growth defects
provides additional support for an immune evasion role for this
miRNA. Thus, it is likely that some TTVs, similar to other viruses
encoding miRNAs [9,10], utilize miRNAs in immune evasion and
to promote their persistence.
Do the TTV encoded miRNAs serve additional noncanonical
functions? While we have focused on possible canonical miRNA
functional roles, we cannot rule out that the TTV miRNAs may
provide additional functional benefits to the virus. For example,
we observe that the TTV miRNAs are encoded proximal to the
major poly A site for the protein coding viral transcripts, and a
similar arrangement is observed in the polyomaviruses SV40,
JCV, and BKV in which the viral miRNAs are encoded proximal
to the poly A site for the late transcripts [26,39]. We hypothesize
that the presence of stemloop structures could provide additional
benefits including the imposition of greater transcriptional
termination of the mRNAs which could be of benefit to viruses
Figure 7. TTV-tth8-miR-T1 or knockdown of NMI inhibits interferon signaling. (A) Schematic of the interferon signaling assay. Target cells
are co-transfected with dual luciferase plasmids (firefly luciferase with interferon-stimulated response element (ISRE) based promoter and
transfections control Renilla luciferase with constitutive promoter) and either re-circularized viral genome, miRNA mimic, or siRNA. Forty-eight hours
later, cells are treated with 100 U/mL Type I interferon. Sixteen hours after interferon treatment, dual luciferase assay is performed. (B) Interferon
signaling assay performed as outlined in Fig. 7A with TTV-tth8 wildtype (WT) and miRNA mutant (MUT) genomic preparations in HEK293T cells.
Relative luciferase activity is normalized to pUC19 vector control (VEC). Error bars indicate SD of three replicates and p-values were calculated using
Student’s t-test. (C) Interferon signaling assay performed as outlined in Fig. 7A with miRNA mimics and siRNAs in HEK293T cells. TTV-tth8 miRNA
mimic (miTTH8) was normalized to negative control miRNA mimic (miNC). NMI siRNA was normalized to negative control siRNA (siNC). Co-
transfection of both a miRNA mimic and siRNA is indicated by a ‘‘/’’ and was normalized to co-transfection of both siNC and miNC. Error bars indicate
SD of three replicates and p-values were calculated using Student’s t-test. Not significant (n.s.) indicates p-value greater than 0.05. (D) Interferon
signaling assay performed as outlined in Fig. 7A with miRNA mimics in HEK293T and ISG15 expression assayed by qPCR following interferon
treatment. TTV-tth8 miRNA mimic (miTTH8) treatment was normalized to negative control miRNA mimic (miNC). NMI siRNA (siNMI) treatment was
normalized to negative control siRNA (siNC). Relative ISG15 expression was determined by comparative Ct method to GAPDH. Error bars indicate SD
of three replicates and p-values were calculated using Student’s t-test. (E) Growth curves of interferon treated B cell lines that stably overexpress the
TTV tth8 miRNA (TTH8) or a negative control irrelevant miRNA (NC) or vector alone (VEC). Viable cells as determined by trypan blue staining were
counted each day and then either mock-treated with BSA or treated with universal type I IFN (+IFN). Data points represent averages of three
independent experiments (each performed in triplicate) on different days and error bars indicate SD of the three experiments.
doi:10.1371/journal.ppat.1003818.g007
Viral MicroRNA Inhibits Interferon Signaling
PLOS Pathogens | www.plospathogens.org 9 December 2013 | Volume 9 | Issue 12 | e1003818
with small circular genomes. Furthermore, we observed evidence
that TTV-tth8 transcripts in both orientations over the miRNA
locus are subject to post-transcriptional cleavage (Fig. 5A). It is
tempting to speculate that this phenomenon could provide benefit
to a small circular virus in the prevention of the accumulation of
double stranded RNA (dsRNA), a potential pathogen associated
molecular pattern [40].
TTVs with human hosts have been noted for their great genetic
diversity despite their limited coding capacity [41]. Here we
identified a new genetic locus encoding miRNAs. Perhaps not
surprisingly, TTVs display significant diversity at this newly
identified locus as well. The TTVs and their diversity are a ripe
area for future evolutionary studies to understand how viral
miRNAs, and noncoding RNAs in general, evolve and how they
influence viral diversity. Strong miRNA candidates were observed
from all five groups of human TTVs as well as some related
primate TTVs (Table S1). However, no strong miRNA candidates
were observed in the related TTMDVs or TTMVs (data not
shown). It is worth noting that deposited sequences of both of these
groups of viruses have shorter NCRs which in some part may be
due to the submission of incomplete viral genomic sequences. It is
also possible that some of these viruses lack miRNA genes and may
have evolved alternative strategies to fulfill any beneficial roles of
the TTV miRNAs. Furthermore, we did not observe strong
miRNA candidates from various non-primate TTVs at the same
locus, but there are relatively few full length reported strains for
most of the TTVs with non-human hosts. Future studies and
sequencing of additional isolates will be needed to address the
roles, if any, of miRNAs in the non-human TTVs and related
anelloviruses.
Can TTVs be harnessed as potential therapeutic vectors? An
attractive quality of TTV is the implied low pathogenicity of TTVs
from lack of strong disease associations and their ubiquitous
nature. Average TTV titers of 10‘4 to 10‘6 genome copies per mL
of blood have been reported for apparently healthy individuals
[42,43]. While the TTV genome itself has limited coding capacity
for transgenes, we have demonstrated that exogenous small RNAs
can be expressed from the viral genome (Fig. 4B). However,
current attempts to vectorize the TTVs may be limited by lack of
fundamental knowledge of TTV biology and limited culture
systems. While the possible use of TTV as a small RNA vector
awaits a more complete understanding of the replication and life
cycle of these viruses, our work at least establishes the ability of
these genomes to readily express a heterologous miRNA.
In summary, we have demonstrated that a ubiquitous human
virus encodes novel miRNAs, one of which may antagonize the
host antiviral response. Our findings bring new insights into the
torque teno viruses as well as their interactions with the host
miRNA machinery and antiviral response.
Methods
Cell Lines
HeLa, HEK293, and HEK293T obtained from American Type
Culture Collection (ATCC) were maintained in DMEM supple-
mented with 10% (vol/vol) FBS and pen-step (Cellgro).
HEK293TT cells [44] were cultured in DMEM supplemented
with 10% (vol/vol) FBS, 1% Glutamax, 1% nonessential amino
acids, and pen-strep (Invitrogen). Dicer wild-type cells (DLD1) and
cells hypomorphic for Dicer activity (DLD1 DicerEx52/2) cell
lines were maintained in RPMI 1640 supplemented with 10%
(vol/vol) FBS and pen-strep. Human B-cell line GM19240 was
obtained from Coriell Institute and maintained in RPMI 1640
supplemented with 15% (vol/vol) FBS and pen-strep.
Plasmids
Cassettes encompassing the predicted miRNA genes were
synthesized by Integrated DNA Technologies (IDT) in the context
of the pIDT-SMART-KAN vector (sequences are listed in Table
S4). SV40 miRNA and MHV68 miRNA expression vectors have
been previously described [12]. RISC Assay Luciferase reporters
were generated with two long oligonucleotides of opposing
orientations, which encoded for two complementary binding sites
for the various miRNAs separated by eight nucleotides. Oligonu-
cleotides were annealed and elongated using Taq polymerase
(New England Biolabs) (98uC 30 s, 98uC 10 s, 55uC 20 s, 72uC
10 s,72uC 5 min). Extended target sites were then cloned into the
XhoI/XbaI site pcDNA3.1dsRluc [39]. NMI wildtype and
mutant 39UTR reporters were synthesized as IDT gBlocks and
subcloned into the XhoI/XbaI sites of pcDNA3.1dsRluc.
pcDNA3.1dsRluc-GAPDH has been previously described [12].
siRNAs and miRNA Mimics
TTV-tth8 miRNA mimics (pAGUAGUUGAGGCGGACG-
GUGGC, pCACCAUCAGCCACACCUACUCA) were synthe-
sized by Sigma. Negative control si/miRNA mimic with Qiagen
All Stars Negative Control sequence (pUUCUCCGAACGUGU-
CACGUdTdT, pACGUGACACGUUCGGAGAAdTdT) was
synthesized by Sigma and has been described previously [45].
Drosha siRNA (pCGAGUAGGCUUCGUGACUUdTdT, pAA-
GUCACGAAGCCUACUCGdTdT) has been previously de-
scribed [23]. NMI specific siRNAs (sc-36089) and negative
control siRNA (sc-37007) were purchased from Santa Cruz
Biotechnology.
Generation of Lentiparticles
TTV-tth8 miRNA or an irrelevant miRNA (ebv-mir-BART4)
was subcloned into the pLB2 CAG P2Gm (Addgene #19752)
lentivector using XhoI and XbaI sites. The following plasmids
were transfected into a T75 of HEK 293T cells using
Lipofectamine 2000 (Invitrogen): 11.7 ug miR expression vector,
3.5 ug pMD2.G (Addgene #12259), 2.9 ug pRSV-Rev (Addgene
#12253), and 5.9 ug pMDLg/pRRE (Addgene #12251).
Supernatant was collected after 24 hours and the HEK293T
cells were given fresh media. The next day, the supernatant was
collected and combined with the previous day supernatant and
0.2 micron filtered. The stocks were titered on 10‘5 HEK293T
cells in 24 well plates. Twenty microliters of serial dilutions of
lentiparticle stocks were added to the cells in triplicate. After
48 hours, the cells were washed with PBS. Lentiparticle titers
were determined by counting the percent of HEK293T cells that
were GFP positive. Transducing units (TU) per mL was
calculated using the following equation: ((Percent positive
GFP6number of cells)/1006 volume of viral dilution added to
each well)61/dilution factor.
Generation of Stable Cell Lines Expressing TTV-tth8
miRNA
5610‘5 GM19240 B-cells (Coriell Institute) were seeded into a
6-well plate. 1 mL of lentiparticles (1610‘6 TU/mL) and 5 ul
polybrene (Sigma-Aldrisch) (10 ug/mL) were added to each well
in duplicate along with a polybrene only control. After 24 hours,
the cells were pelleted and resuspended in fresh media along with
puromycin (Sigma-Aldrich) (0.5 ug/mL). Cells were passed every
3 days in media that contained puromycin. The control B-cells did
not survive past 2 passages with puromycin selection. After 17
days, selection was removed and cells were used for subsequent
experiments.
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Generation of Recombinant Viruses
TTV-tth8 miRNA mutant virus plasmid (pUC-TTV-MUT)
was generated by digestion of pUC-TTV-tth8 with AflII followed
by treatment with mung bean nuclease (New England Biolabs) and
self-ligation with T4 DNA ligase (New England Biolabs). The
introduction of the expected 4 nt deletion was confirmed by
sequencing. The pUC-TTV-SV40 miRNA virus plasmid was
generated by PCR amplifying the miRNA encoding sequence of
SV40-776 with primers PRIMER1, PRIMER2 and cloning into
the AflII site of pUC-TTV-tth8. The introduction of the SV40
miRNA sequence in the same orientation as the wildtype miRNA
was confirmed by sequencing.
miRNA Prediction Software
Python scripts to predict pre-miRNA like structures in viral
genomic sequence utilized the RNAfold [46] and Biopython [47]
software packages. Scripts and associated data are freely available
at https://code.google.com/p/mirna/
Small RNA Northern Blots
Small RNA Northern blot analysis was performed as previously
described [48]. Probe sequences are listed in Table S4.
Preparation of Viral Genomes
Viral genome containing plasmids (150 ug) were digested with
SalI-HF to release a linear viral genome sequence. Digests were
heat inactivated and used to prepare dilute 30 mL T4 DNA ligase
reactions. Ligations were incubated at 15C for 48 hours and then
purified with HiPure Plasmid Maxiprep Kit (Invitrogen).
Cell Culture Replication System
In vitro cell culture replication of TTV-tth8 and derivative
viruses was carried out in HEK293TT cells transfected with viral
genome preparations as previously described [15].
DpnI Protection Assay
Genomic DNA was harvested by phenol/chloroform extraction
[49]. Twenty micrograms of DNA was digested to completion with
EcoRV-HF with or without DpnI. DpnI digest control was
performed on twenty micrograms of DNA from pUC transfected
HEK293TT cells spiked with 1 ng of TTV tth8 viral genome
preparation. Southern blots were performed as described below [25].
Southern Blots
Samples were run on 1% agarose TAE gels. Following
electrophoresis, gels were soaked in 0.25 M HCL for 15 minutes.
Next, gels were soaked in Southern Transfer Buffer (STB) (20 g/L
NaOH, 87.5 g/L NaCl). Transfers to HyBond N+ membranes
were performed overnight blot in STB. After transfer, membranes
were soaked in neutralization buffer (100 mLTris pH8, 50 mL 206
SSC, 350 mLH2O). Membranes were pre-hybridized for 1 hour at
60C in ExpressHyb Buffer (Clontech). Radiolabeled probes were
generated using the Rediprime II DNA Labeling System (GE
Healthcare) using SalI linearized TTV-tth8 genomic DNA. Probes
were hybridized overnight at 60C. Blots were washed twice for
20 minutes with Wash Buffer 1 (26 SSC, 0.1% SDS) at 60C and
twice for 20 minutes with Wash Buffer 2 (0.16SSC, 0.1% SDS) at
50C. Storage phosphor screens (GE Healthcare) were exposed and
then scanned using a Personal Molecular Imager system (Biorad).
Synthetic Gene Small RNA Sequencing
Pooled, multiplexed small RNA sequencing was performed as
previously described [12]. Genomic CDS maps were generated
from the indicated reference sequence sequences with the
Geneious software package (Biomatters).
Cell Culture Replication System Small RNA Sequencing
HEK293TT cells were transfected with recircularized genome
preparations or pUC control vector. Total RNA was harvested
with PIG-B [50] at thirty hours posttransfection. Three hundred
micrograms of total RNA was size fractionated on a 15% (vol/vol)
UREA-PAGE gel and used to prepare small RNA libraries for
Illumina small RNA sequencing. Sequencing adapter sequences
were trimmed from the reads using custom Python scripts, and any
sequences with ambiguous calls or less than 18 nt in length after
trimming were removed from further analysis. The preprocessed
reads were then mapped to the TTV-tth8 wt (AJ620231) or
miRNA mutant genomic sequences using the SHRiMP2 software
package [51]. 59 start site counts and coverage were calculated
using custom Python scripts and visualized using the gnuplot
software package. Genomic CDS map was generated from the
TTV-tth8 reference sequence with the Geneious software package
(Biomatters).
Analysis of In Vivo RNA Sequencing Data
SRA data files SRR039190 and SRR039191 were retrieved
from NCBI. The SRA formatted files were converted to FASTA
format and sequencing adapters were trimmed with custom
Python scripts. The pre-processed files were mapped to a
collection of TTV genomic sequences (Table S2) using the
SHRiMP2 software package.
Precursor miRNA Structure Prediction
miRNA stemloop secondary structures were generated using the
Mfold RNA folding prediction Web server [52,53] or the RNAfold
prediction Web server [46], as indicated.
RISC Activity Assay
Twelve well plates of HEK293 cells were co-transfected with
five nanograms of Renilla luciferase based 39UTR reporter
(pcDNA3.1dsRluc [39]), five nanograms of firefly reporter
(pcDNA3.1dsLuc2CP [39]) and one microgram of either empty
vector (pIDT-SMART-KAN) or indicated TTV miRNA expres-
sion vector using the Turbofect reagent (Fermentas). Twenty-four
hours later, cells were harvested and assayed with the Dual-Glo
Luciferase Assay System (Promega). Luciferase activity was
measured with a Luminoskan Ascent luminometer (Thermo
Electronic). Student’s t-test was used to assess statistical signifi-
cance of observed differences.
RNA Polymerase Activity Assay
HEK293 or HEK293T cells as indicated were transfected with
viral genome preparations or miRNA expressions vectors. Two
hours later, cells were treated with 50 ug/mL a-amanitin (Sigma).
Total RNA was harvested with PIG-B [50] at 24 hours
posttransfection and Northern blot analysis was performed.
Drosha Dependence Assay
HEK293T cells were transfected with 20 nM Drosha siRNA or
negative controls siRNA using Lipofectamine RNAi-MAX (In-
vitrogen). Twenty-four hours later, a second transfection of siRNA
was performed followed by transfection of miRNA expression
vectors using the Turbofect reagent according to the manufactur-
er’s recommendations (Fermentas). Twenty-four or thirty hours
later, total RNA was extracted with PIG-B and Northern blot
analysis was performed.
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Dicer Dependence Assay
Dicer wild-type cells (DLD1) and cells hypomorphic for Dicer
activity (DLD1 DicerEx52/2) [24] were transfected with miRNA
expression vectors using the Turbofect reagent (Fermentas).
Twenty-four or thirty-six hours posttransfection, total RNA was
extracted with PIG-B and Northern blot analysis was performed.
Microarray Analysis
HEK293TT cells were transfected with recircularized genome
preparations or pUC control vector [15]. One biological replicate
was used for each treatment. Total RNA was harvested with PIG-
B at thirty hours posttransfection. RNA was treated with DNase
(Qiagen) and purified using RNeasy Minielute kit (Qiagen). RNA
integrity was verified on a 1.0% agarose (Formaldehyde, MOPS)
denaturing gel. The purified RNA was used as a template to make
biotin labeled cRNA using an Illumina TotalPrep RNA Ampli-
fication Kit (Ambion) according to the manufacturer’s guidelines.
Labeled cRNA was precipitated overnight with isopropanol and
sodium acetate. Biotinylated cRNA is hybridized to Illumina
HumanHT-12 v4.0 BeadArray chips at the KECK Institute (Yale
University) according to Illumina’s protocols. Image analysis was
carried out with BeadStudio software (Illumina) and initial quality
controls (housekeeping genes, hybridization controls, and negative
control probes) and data analysis (p-values for detection based on
control probes and quantile normalization) were carried out with
BeadStudio according to the instructions provided by Illumina. To
identify candidate miRNA targets, the following criteria were
applied: putative targets must be lower in the wildtype sample than
the mutant or SV40 control and a seed complementary sequence
must be present in the 39UTR sequence of the candidate mRNA.
Microarray data has been deposited in the GEO database.
Candidate targets were then subject to subsequent validation
assays as described in the Results section.
Western Immunoblot Analysis
Fifty percent confluent six well plates of HeLa cells were
transfected with 100 pmol of the indicated siRNA or miRNA
mimic using Lipofectamine 2000 (Invitrogen). Forty-eight hours
later, the transfected HeLa cells were split 1:4. The next day, a
second transfection was performed. Forty-eight hours later,
lysates were prepared with RIPA buffer (0.1% SDS, 1% Triton
X-100, 1% deoxycholate, 5 mM EDTA, 150 mM NaCl, and
10 mM Tris at pH 7.2) including Complete, Mini Protease
Inhibitor tablets (Roche). Twenty micrograms of the total lysate
was separated in 10% SDS-polyacrylamide gels and transferred
to PVDF membranes (Millipore). Membranes were blocked with
Odyssey blocking buffer (LI-COR). Primary antibodies used
were Nmi (N-16): sc-9482 (Santa Cruz Biotechnology) and b-
Actin (C4): sc-47778 (Santa Cruz Biotechnology). Blots were
probed with a 1:1000 dilution of each primary antibody in
Odyssey blocking buffer. Blots were washed four times with
Phosphate Buffered Saline including 0.1% Tween 20 (PBST).
IRDye 800CW and IRDye 680LT secondary antibodies (LI-
COR) were diluted 1:10,000 in Odyssey blocking buffer
containing 0.1% Tween 20 and 0.05% SDS. Blots were washed
four times with PBST. Blots were scanned on an Odyssey CLx
infrared imaging system (LI-COR). Band intensities were
measured with Image Studio software (LI-COR). Three inde-
pendent experiments were performed on different days for
quantification and Student’s t-test was used to assess statistical
significance of observed differences.
Interferon Signaling Assay
HEK 293T cells were seeded in 96-well plates. The next day,
1 ul Luciferase reporter mix (5 ng/ul pcDNA3.1dsRluc [39] and
20 ng/ul pISRE-Luc (Clonetech)) was co-transfected along with
either RNA mimic (25 pmol/well), siRNA (25 pmol/well) or
100 ng re-circularized TTV genome. Mixed DNA/RNA trans-
fections were performed with Lipofectamine 2000 (Invitrogen) and
DNA only transfections were performed using the Turbofect
transfection reagent according to the manufacturer protocol
(Fermentas). In cases where both a miRNA mimic and siRNA
were co-transfected, 25 pmol of both an RNA mimic and siRNA
were used (50 pmol total) along with the Luc reporter mix. Each
experimental condition was transfected into 6 wells (2 sets of
triplicates-3 control wells and 3 experimental wells). After
48 hours, the media was replaced with new media with or without
100 u/ml of universal type I interferon (PBL Interferon Source).
16 hours after IFN treatment, a dual-luciferase assay was
performed. Firefly luciferase was normalized to Renilla luciferase
expression in order to control for transfection differences. Fold
induction of the ISRE ffLuc reporter was calculated by dividing
the comparable experimental wells by the control wells. Induction
of each condition is relative to the negative control. Experiments
with HeLa cells were conducted in a similar fashion except
miRNA/siRNA transfections were performed in six well plates
prior to seeding 96 well plates as described below. The HeLa cells
were transfected with 50 pmol of siRNA or mimic (100 pmol for
combined siRNA/miRNA transfection) using Lipofectamine 2000
(Invitrogen). Forty-eight hours later, cells were split 1:4. The next
day the cells were subject to a second round of transfection.
Twenty four hours later, the HeLa cells were plated in 96 well
plates. The next day, the interferon signaling assay was conducted
as described above for HEK293T cells.
Interferon Signaling Assay with Quantitative RT-PCR
HEK 293T cells in T25 plates were transfected with 7.5 ug
plx304 plasmid (DNASU). Forty-eight hours later, the cells were
replated in media containing 10 ug/mL Blasticidin S (Sigma-
Aldrich). Antibiotic treatment was continued for four days and
then removed for subsequent experiments. 12-well plates of HEK
293T were co-transfected with 40 ng pcDNA3.1dsRluc [39],
160 ng pISRE-Luc (Clonetech), and 80 pmol of the indicated
siRNA or miRNA mimic using Lipofectamine 2000 (Invitrogen).
Twenty-four hours later, the media was replaced with fresh media
containing 100 units/ml of universal type I interferon (PBL
Interferon Source). Sixteen hours after interferon treatment, total
RNA was extracted using TRIzol Reagent (Invitrogen). Ten
micrograms of total RNA was treated with one unit of DNAse I
(NEB) for 30 minutes at 37C. DNAse treated RNA was ethanol
precipitated. Two and a half micrograms of DNAse treated RNA
was reverse transcribed using SuperScript III (Invitrogen) with
oligo dT(20) primer (IDT). The cDNA was diluted to 100 ul.
qPCR reactions consisted of 2 ul diluted cDNA, 1 ul (500 pmol) of
each primer, 10 ul PerfeCta SYBR Green FastMix, ROX
(Quanta Biosciences), and 6 ul water. ISG15 and GAPDH
primers are listed in table S4. Real-time PCR program consisted
of 2 minute incubation at 95uC followed by 40 cycles (15 s at
95uC, 30 s at 55uC, 15 s at 60uC). All qRT-PCR was performed
on a StepOnePlus Real-Time PCR System (Applied Biosystems).
Comparative Ct method was used with GAPDH serving as
internal control gene for ISG15. Average relative quantities of
three biological replicates each assayed in triplicate are reported.
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Interferon Growth Assay
3610‘4 cells of the indicated pooled stable cell lines were seeded
into a 6 well plate in 2 mL growth media in triplicate. Viable cells
as assayed by trypan blue (Cellgro) staining were counted (Day 1)
then 750 units universal type I interferon (IFN) (PBL Interferon
Source) or 1 ug bovine serum albumin (BSA) (Sigma-Aldrich)
control was added to the wells. Viable cell numbers were counted
every day and after each cell count 750 units IFN or 1 ug BSA was
added to the wells. Three independent experiments were
performed on different days in triplicate.
Supporting Information
Code S1 miRNA Prediction Code. Archive containing
miRNA prediction code. Most recent version and additional files
available at: https://code.google.com/p/mirna/.
(GZ)
Figure S1 TTV miRNAs expressed from synthetic
vectors are generated by the canonical host miRNA
biogenesis pathway. (A) Northern blot analysis of RNA from
HEK293T cells transfected with synthetic miRNA expression
vectors with or without treatment with the RNA pol II inhibitor a-
amanitin. Ethidium bromide stained low molecular weight RNA is
shown as a load control. (B) Northern blot analysis of RNA from
HEK293T cells co-transfected with synthetic miRNA expression
vectors and either Drosha siRNA (siDrosha) or negative control
siRNA (siNC). Ethidium bromide stained low molecular weight
RNA is shown as a load control. (C) RISC reporter assay for
synthetic TTV miRNA expression vectors. HEK293T cells were
co-transfected with either empty miRNA expression vector
(Vector) or indicated synthetic TTV miRNA expression vector
and both firefly luciferase control and Renilla luciferase based
reporter plasmids with vector UTR (Vector) or two sites perfectly
complementary to the indicated miRNA. The average relative
Renilla luciferase activity normalized to firefly luciferase activity of
three replicates is shown. Error bars indicate SD of three replicates
and p-values were calculated using Student’s t-test.
(TIF)
Figure S2 Characterization of cell culture genome
replication of wildtype and miRNA mutant TTV-tth8.
Southern blot analysis of DpnI protection assay conducted on in
vitro cell culture replication of wildtype TTV-tth8 (WT) and
miRNA mutant TTV-tth8 (MUT). Lane NC is pUC transfected
HEK293TT DNA and lane Ctrl is pUC transfected HEK293TT
DNA spiked with viral genome prep. Replicated label indicates
expected migration for linearized full length genomes. Input label
indicates largest DpnI cleavage fragment.
(TIF)
Figure S3 Knockdown of NMI by siRNA. (A) Confirmation
of siRNA mediated knockdown of NMI. Western blot analysis was
performed on protein lysates from HeLa cells transfected with
siRNA specific to NMI (siNMI) or negative control siRNA (siNC).
(B) Interferon signaling assay performed in HeLa cells. Assay is
performed as in Fig. 7C except HeLa cells were subjected to two
rounds of mimic and siRNA transfection prior to plating for
interferon signaling assay. Error bars indicate SD of three
replicates and p-values were calculated using Student’s t-test.
Not significant (n.s.) indicates p-value greater than 0.05.
(TIF)
Table S1 Pre-miRNA stemloop predictions for human
TTVs and related animal viruses.
(XLS)
Table S2 Accessions for TTV genomic sequences used
in small RNA sequencing analysis.
(XLS)
Table S3 Microarray analysis and list of putative TTV-
tth8-miR-T1 targets.
(XLSX)
Table S4 Oligos and synthetic sequences used in this
study.
(XLS)
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